Cargando…
Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5
Castration resistant-prostate cancer is largely impervious to feather hormonal therapy and hence the outlook for patients is grim. Here we use an approach to attach the recently discovered Achilles heel. The experimental treatment established in this study is based on the recent discovery that it is...
Autores principales: | Al-Jameel, Waseem, Gou, Xiaojun, Forootan, Shiva S., Fayi, Majed Saad Al, Rudland, Philip S., Forootan, Farzad S., Zhang, Jiacheng, Cornford, Philip A., Hussain, Syed A., Ke, Youqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458187/ https://www.ncbi.nlm.nih.gov/pubmed/28415688 http://dx.doi.org/10.18632/oncotarget.16055 |
Ejemplares similares
-
Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5
por: Al-Jameel, Waseem, et al.
Publicado: (2020) -
The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance
por: Al Fayi, Majed Saad, et al.
Publicado: (2016) -
Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter
por: Forootan, Farzad S., et al.
Publicado: (2016) -
Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ
por: Al-Jameel, Waseem, et al.
Publicado: (2019) -
Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer
por: Chen, Danqing, et al.
Publicado: (2014)